Health ConditionsRosacea is a common, chronic inflammatory skin disease of poorly understood origin. It is a chronic cutaneous inflammatory disease that affects the facial skin and can be categorized clinically into papulopustular, erythematotelangiectatic, ocular, and phymatous rosacea. Common clinical presentations include flushing, erythema, telangiectasia, papules, pustules, rhinophyma, and ocular involvement.
According to a meta-analysis published in 2018, which included studies from multiple continents, the prevalence of rosacea in the general population ranges from 0.09% to 22.41%, with a pooled proportion of 5.46%. Rosacea prevalence is highest (between 2.7 and 10%) in patients of northern European or Celtic heritage. Humans with fair skin (Fitzpatrick skin phenotypes I–II) are more likely to be affected, whereas Asians and African Americans are less affected, indicating a genetic component.
Although most patients are female, males exhibit a longer median disease duration and a higher prevalence of the phymatous subtype; females are more frequently diagnosed with other rosacea subtypes, highlighting gender-specific variations in disease presentation.
Rosacea typically presents during adulthood, though it can rarely affect children. There are four clinical subtypes of rosacea based on the predominant signs and symptoms: erythematotelangiectatic, papulopustular, phymatous, and ocular, and the subtypes are not mutually exclusive.
The National Rosacea Society developed a standard classification system in 2002 based on the presence of at least one primary feature (transient or persistent erythema, inflammatory papules or pustules, or telangiectasia) and classified rosacea into four subtypes: erythematotelangiectatic rosacea (ETR), papulopustular rosacea (PPR), phymatous rosacea (PhR), or ocular rosacea. This classification system was updated in 2017 and replaced with a phenotype-based approach to diagnosis.
Clinical and histopathological characteristics of rosacea make it a fascinating "human disease model" for learning about the connection between the cutaneous vascular, nervous, and immune systems. Based on its clinical features (flushing, chronic inflammation, fibrosis) and trigger factors, a complex pathobiology involving different regulatory systems can be anticipated; the precise interplay of the various dysregulated systems (immune, vascular, nervous) is still poorly understood.
The importance of the vascular cutaneous system in rosacea is supported by the clinical and histopathological characteristics of flushing, erythema, and telangiectasia; edema results from plasma extravasation (i.e., the vascular leakage of blood vessels), and rosacea is characterized by edema derived from blood and lymphatic vessels. Vasodilation of blood vessels by immune responses may lead to telangiectasia and erythema.
Inflammation from rosacea is also characterized by innate immune system anomalies, with an increase in the expression of epidermal proteases and production of pro-inflammatory cathelicidin peptides. Demodex and ultraviolet radiation can cause the elevated expression of TLR-2. TLR-2 regulates the release of KLK-5, which disrupts the epidermal barrier and activates the cleavage of hCAP-18 into LL-37. LL-37 stimulates tissue inflammation, vasodilation, and angiogenesis in rosacea.
Recent molecular studies have revealed altered cytokine expression (e.g., IL-1β, IL-6, IL-36 family), aberrant activation of signaling pathways (STAT3, NF-κB, MAPKs), and enhanced expression of innate immune receptors such as TLR2, TLR4, and TLR7, all of which promote chronic inflammation, angiogenesis, and barrier dysfunction.
In early disease manifestations and milder stages, dysfunction of neurovascular regulation and the innate immune system seem to be driving forces in rosacea pathophysiology. At the molecular level, the disorder's pathogenesis involves dysregulation of transient receptor potential (TRP) channels, which act as nonselective Ca²⁺-permeable ion channels with critical sensory and signaling functions; their activation triggers intracellular Ca²⁺ influx, initiating downstream cascades that promote the release of vasoactive and pro-inflammatory mediators.
Abnormal functioning of TLR-2, KLK-5, and cathelicidin or vitamin D response along with epidermal barrier disruption may contribute to the dysregulation of innate immunity and augment the inflammatory cascade in rosacea; furthermore, Th1 and Th17 cell-mediated immune responses might affect the adaptive immunity of patients with rosacea. Chronic inflammation characterized by Th1 cells, macrophages, and mast cells because of sustained innate immune and neurogenic stimulation results in induction of profibrotic growth factors.
Increasing evidence suggests that the gut microbiota is significantly involved in the pathogenesis of rosacea, playing an important role in the inflammatory cutaneous response. Associations with additional GI pathologies, including small intestinal bacterial overgrowth (SIBO), irritable bowel syndrome (IBS), and inflammatory bowel disease (IBD), have been investigated, as well as Helicobacter pylori infection.
Twin cohort analysis demonstrated significantly higher concordance in rosacea severity among monozygotic versus dizygotic twins, confirming substantial genetic contributions to disease development; approximately 46% of the variation in rosacea severity was attributed to genetic factors, indicating that genetic susceptibility is a key component in the pathogenesis of rosacea.
The contributing pathogenic mechanisms of rosacea can be categorized into four major categories which can interact with each other: external triggers (e.g., exposure to UV radiation and Demodex mites), genetic predisposition, immune dysregulation, and neurovascular dysregulation.
Pathogenic factors include: (1) exposure to UV radiation; (2) reactive oxygen species (including superoxide and hydroxyl radicals, hydrogen peroxide and singlet oxygen); (3) vascular hyperreactivity; (4) neuropeptides; (5) exacerbation of innate immune response; (6) microbes, in particular H. pylori and environmental aggressors, such as Demodex mite.
Among the triggering factors, Demodex proliferation directly disrupts the epidermal barrier. The edema that results from rosacea-associated vascular changes undoubtedly favors the colonization and multiplication of Demodex folliculorum; this parasite creates inflammation, directly and indirectly, which is seen in the papules and pustules as well as granulomas.
H. pylori exacerbates inflammation, triggering the release of pro-inflammatory cytokines such as TNF-α and IL-8. Individuals with rosacea were 13-fold more likely to develop small intestinal bacterial overgrowth (SIBO) compared to the control group; SIBO has been proposed to augment intestinal permeability, which in turn may lead to the translocation of bacterial components and proinflammatory cytokines into the systemic circulation, subsequently triggering skin inflammation.
A decrease in the Lactobacillus genus, Prevotella copri, Lachnospiraceae, and Faecalibacterium within the gut microbiota may initiate inflammation related to rosacea, as these bacterial species are crucial for regulating the intestinal mucosa.
Recent reports on rosacea have shown a significant association with cardiovascular, gastrointestinal, and psychiatric diseases, all of which may affect morbidity and mortality among these patients. Statistically significant association with rosacea has been demonstrated with depression (n = 117,848 patients), hypertension (n = 18,176), cardiovascular diseases (n = 9,739), anxiety disorder (n = 9,079), dyslipidemia (n = 7,004), diabetes mellitus (n = 6,306), migraine (n = 6,136), rheumatoid arthritis (n = 4,192), Helicobacter pylori infection (n = 1,722), ulcerative colitis (n = 1,424), and dementia (n = 1,194). Limitations of this body of evidence include the accuracy of published data, potential patient selection, and possible confounding factors; the true nature of the drawn correlations is uncertain, and causality cannot be established.
A growing number of comorbidities are being reported in rosacea; in a large case-control study, the frequency of hypothyroidism was significantly increased in rosacea patients, while no association between hyperthyroidism and rosacea was shown.
Patients with rosacea have been reported to have low self-esteem, social avoidance, and emotional stress; furthermore, psychosocial factors such as stress and social anxiety may trigger and cause further deterioration of rosacea, resulting in higher incidences of depression and anxiety.
Many dietary triggers, including hot beverages, alcohol, spicy foods, caffeine, vanilla, cinnamon, niacin, marinated meats, and dairy products, have been postulated for this disease; however, there is a lack of well-designed and controlled studies evaluating the causal relationship between rosacea and dietary factors.
A cohort study of 82,737 women from the Nurses' Health Study II (1991–2005) measured alcohol intake every four years during follow-up; over 14 years, 4,945 incident cases of rosacea were identified. Compared with never drinkers, increased alcohol intake was associated with a significantly elevated risk of incident rosacea (P for trend <0.0001); the multivariable-adjusted HRs were 1.12 (95% CI 1.05–1.20) for alcohol intake of 1–4 g/day, and 1.53 (1.26–1.84) for ≥30 g/day. Among individual types of alcoholic beverages, only white wine and liquor were significantly associated with the incident risk of rosacea, suggesting that developing rosacea and the phenomenon of flushing with red wine intake leading to rosacea exacerbation are distinct phenomena.
Foods with capsaicin may affect rosacea due to capsaicin's ability to affect pain receptors triggered by warmth; this includes chili peppers, hot sauce, and jalapeños. Research funded by the National Rosacea Society found that triggers such as spicy foods and alcohol cause keratinocytes (the most common cell type in the outermost layer of skin) to produce a protein known as transient receptor potential vanilloid 4 (TRPV4). Studies have varied on the severity of spicy foods on rosacea; while spicy foods may aggravate symptoms like flushing, it could be independent of rosacea subtype.
Histamine-rich foods, including fermented products, spinach, tomatoes, and certain fruits, can exacerbate symptoms by promoting vasodilation and inflammation, particularly in individuals with histamine intolerance, where diminished diamine oxidase activity leads to histamine accumulation and heightened sensitivity. The most frequently reported triggers include alcohol, spicy food, cinnamaldehyde-containing foods (e.g., tomatoes, citrus fruits, chocolate), hot drinks, and histamine-rich foods (e.g., aged cheese, wine, processed meats).
In one survey by the National Rosacea Society of over 400 patients, 78% had altered their diet due to rosacea, and of this group, 95% reported a subsequent reduction in flares; triggers included heat-related, alcohol-related, capsaicin-related, and cinnamaldehyde-related categories; specifically, hot coffee (33% described it as a trigger) and hot tea (30%) acted as triggers.
The relationship between caffeine and rosacea is complex; while caffeine's vasoconstrictive, antioxidant, and immunosuppressive properties could theoretically mitigate rosacea symptoms, its potential role as a trigger remains debated; notably, a large cohort study reported an inverse association between coffee consumption and rosacea risk, suggesting a protective effect of coffee-derived caffeine.
A study of diet and rosacea found that frequent consumption of fatty foods and tea was associated with a higher risk of redness and swelling in rosacea, while frequent dairy consumption was negatively correlated with redness or bumps and pimples. Alcohol worsens flushing and fatty food triggers both erythematotelangiectatic and phymatous rosacea in susceptible individuals.
Niacin, or vitamin B3, found in foods such as liver, tuna, and peanuts, activates TRPV1 channels and niacin receptors, causing flushing and potentially worsening rosacea.
Some food items appear to play a protective role, such as omega-3, which appears to protect against ocular rosacea. Some evidence exists supporting the use of supplementary omega-3 fatty acids in ocular rosacea.
What it is: Azelaic acid (AZA) is a non-phenolic, saturated dicarboxylic acid with nine carbon atoms, naturally produced by the yeast Malassezia; it has diverse physiological activities, including antibacterial, anti-keratinizing, antimelanogenic, antioxidant, and anti-inflammatory effects.
Traditional use: Azelaic acid is not historically documented in traditional herbal medicine; its relevance to rosacea emerged through modern pharmaceutical dermatology in the late 20th century.
Scientific evidence: Azelaic acid is widely used in dermatology and is FDA-approved for treating papulopustular rosacea. A systematic review published in JAMA Dermatology, which assessed five randomized controlled trials involving 873 patients, found that both 15% azelaic acid gel and 20% azelaic acid cream significantly reduced inflammatory lesion counts and erythema severity in people with papulopustular rosacea. Evidence strength: strong — supported by multiple RCTs, systematic review, and regulatory approval.
What it is: Niacinamide, a water-soluble form of vitamin B3, reduces symptoms by decreasing sebum production, reducing inflammation, and strengthening the skin barrier through its antibacterial and anti-inflammatory properties.
Traditional use: Niacin (as nicotinic acid) has a long history of use in nutritional medicine for pellagra prevention and cardiovascular support, though its application to inflammatory skin conditions like rosacea is a product of 20th-century dermatological research.
Scientific evidence: Vitamin B3 derivatives, such as topical 1-methylnicotinamide 0.25% and NADH 1%, improved rosacea symptoms in 76.4% (26/34) and 80% of patients, respectively, in reviewed studies. Vitamin B3 derivatives such as topical 1-methylnicotinamide 0.25% and NADH 1% improved symptoms in these proportions of patients across reviewed clinical investigations. Evidence strength: preliminary to moderate — small studies; larger, well-controlled trials are lacking.
What it is: Zinc is an essential trace mineral with established anti-inflammatory, antioxidant, and antimicrobial properties.
Traditional use: Zinc preparations (e.g., zinc oxide) have been used topically in traditional European and Asian medicine for wound healing and skin inflammation for centuries.
Scientific evidence: In a double-blind, placebo-controlled study, zinc sulfate 100 mg three times daily was found to be a good treatment for rosacea with significant improvements in the rosacea severity score. Zinc sulfate solution 5% significantly reduced acne rosacea severity, with 40% and 60% of patients exhibiting a moderate or good response, respectively. Zinc, known for its anti-inflammatory and antioxidant properties, also supports skin health, with dietary sources including shellfish, dairy, and whole grains, although the effectiveness of zinc supplementation remains uncertain. Evidence strength: preliminary to moderate — small-to-medium-sized trials with positive signals, but larger confirmatory studies are needed.
What it is: Long-chain omega-3 polyunsaturated fatty acids (EPA and DHA), found in oily fish and algal oils, have well-characterized systemic anti-inflammatory effects.
Traditional use: Consumption of oily fish has been part of Nordic and East Asian traditional diets for millennia, associated empirically with skin and eye health.
Scientific evidence: Omega-3 fatty acids showed significant improvement in alleviating xerophthalmia in 64% of patients with ocular rosacea. Omega-3 appears to protect against ocular rosacea specifically. Evidence strength: preliminary for skin subtypes; moderate for ocular rosacea — limited number of trials, and most evidence is from small studies or survey-based data.
Traditional use: Green tea has been consumed for over 2,000 years in Chinese and Japanese traditional medicine, where it has been applied topically and orally for its anti-inflammatory, astringent, and antioxidant properties in skin conditions.
Scientific evidence: EGCG (epigallocatechin gallate) from green tea reduces inflammation, oxidative stress, and may inhibit Demodex. One preliminary study found some evidence that a cream made from green tea may provide benefits for rosacea. Evidence strength: preliminary — evidence is limited to small studies and in vitro data; large, rigorous RCTs are absent.
Traditional use: Chrysanthellum indicum, a medicinal plant commonly called African wild daisy, is reported to have been used traditionally to treat conditions such as inflammation, infections, migraine, and various skin disorders. It is used primarily in West African and tropical Asian traditional medicine.
Scientific evidence: A substantial (246-participant) twelve-week double-blind study found that a cream containing 1% Chrysanthellum indicum significantly improved rosacea symptoms compared with placebo. Extracts from Chrysanthellum indicum contain flavonoid derivatives and saponins, which have demonstrated antioxidant properties, including anti-radical and anti-lipoperoxidant effects. Evidence strength: moderate — a notable placebo-controlled RCT supports topical efficacy, though independent replication is limited.
Traditional use: Licorice has long been used in alternative medicine to treat various inflammatory conditions due to its complex botanical composition. It is documented in Traditional Chinese Medicine, Ayurveda, and European herbal traditions as an anti-inflammatory and skin-soothing agent.
Scientific evidence: Glycyrrhiza glabra is known to be especially rich in flavonoids and saponins (glabridin, glycyrrhizic acid, glycyrrhizin, licochalcone, and liquiritigenin), and some of the most studied compounds — glabridin and glycyrrhizin — are found in higher quantities and have anti-irritant and anti-inflammatory properties. Because it inhibits the generation of superoxide anion and cyclooxygenase activity, licorice has been demonstrated to have anti-inflammatory properties. A complex study showed that Glycyrrhiza glabra leaf extract has high antioxidant and anti-inflammatory abilities, inhibiting LPS-induced expression of TNF-α, IL-1, and IL-6. Evidence strength: preliminary — mostly in vitro and small clinical data; systematic clinical evidence for rosacea specifically remains limited.
What it is: Vitamin A and its derivatives (retinoids) are fat-soluble compounds essential for epithelial differentiation and immune regulation.
Traditional use: Vitamin A-rich foods (liver, fish oils) have been used in traditional medicine for skin and eye conditions; topical retinoids were introduced into dermatology in the late 20th century.
Scientific evidence: Vitamin A derivatives, specifically oral isotretinoin, demonstrated significant efficacy, with a 90% reduction in lesions, complete remission in 24% of patients, and marked improvement in 57% of patients. This evidence, however, relates to a pharmaceutical-grade prescription drug rather than dietary vitamin A supplementation. Outcomes for vitamin D, vitamin C, and zinc supplementation varied across studies. Evidence strength for dietary or over-the-counter vitamin A supplementation: insufficient — data is primarily from pharmaceutical isotretinoin trials, not supplemental vitamin A.
What it is: Vitamin D is a fat-soluble secosteroid produced in skin upon UV exposure and obtained from diet and supplements.
Traditional use: Sunlight exposure has historically been recognized as a source of health and skin vitality; dietary sources (oily fish, cod liver oil) were used in folk medicine for inflammatory and immune conditions.
Scientific evidence: Vitamin D induces keratinocyte cathelicidin overexpression, which then initiates a pro-inflammatory cascade — this indicates vitamin D may act as a trigger of inflammation in susceptible individuals via the UV-cathelicidin pathway. Abnormal functioning of TLR-2, KLK-5, and cathelicidin or vitamin D response along with epidermal barrier disruption may contribute to the dysregulation of innate immunity and augment the inflammatory cascade in rosacea. Outcomes for vitamin D supplementation varied across studies. Evidence strength: preliminary and mixed — the role of vitamin D in rosacea is complex and context-dependent; supplementation outcomes are inconsistent across studies.
Traditional use: Fermented foods containing live microorganisms — such as kefir, yogurt, sauerkraut, and kimchi — have been consumed across European, Asian, and Middle Eastern cultures for centuries for digestive and general health benefits.
Scientific evidence: A formulation containing Vitreoscilla filiformis probiotic fractions demonstrated notable reductions in erythema, Demodex density, and transepidermal water loss, as well as improvements in patient-reported outcomes; these findings indicate that topical probiotics may directly enhance skin barrier function and modulate immune responses locally. In a randomized clinical trial, in the probiotic group 57% of patients experienced complete clinical remission compared to 28% in the control group. Despite promising results, the evidence supporting the use of probiotics in the treatment of rosacea remains relatively limited; further clinical trials are necessary to evaluate and compare the effectiveness of various probiotic strains and different methods of delivery. Evidence strength: preliminary — early-phase RCTs show positive signals, but evidence is not yet sufficient for formal evidence-based recommendations.
Traditional use: Tea tree oil is derived from the Australian native plant Melaleuca alternifolia and has been used in Aboriginal Australian traditional medicine for wound healing and skin infections. It has been incorporated into Western naturopathic practice in the 20th century for antimicrobial and anti-inflammatory applications.
Scientific evidence: A meta-analysis evaluating the efficacy of different anti-Demodex treatments concluded that topical and systemic ivermectin, topical ivermectin-metronidazole, and topical tea tree oil are promising anti-Demodex interventions. The relevance of tea tree oil for rosacea is primarily tied to its anti-Demodex activity. Evidence strength: preliminary — included in meta-analysis of anti-Demodex interventions, but dedicated large RCTs for rosacea outcomes are lacking.
Traditional use: Aloe vera gel has been used in traditional medicine across Africa, the Middle East, and Asia for skin inflammation, burns, and wound healing for over 3,000 years. It appears in Ayurvedic, Egyptian, and traditional Arab healing systems.
Scientific evidence: A small study published in 2008 found a cream containing 0.5% aloe vera extract was more effective than a placebo in reducing redness and inflammation. Evidence strength: very preliminary — single small study; large confirmatory trials are absent.
Traditional use: Kanuka honey, derived from Kunzea ericoides (a New Zealand native plant), has been used in Māori traditional healing for wound care and skin ailments.
Scientific evidence: Participants in a 2015 study saw improvement with kanuka honey. The study referenced is a randomized controlled trial published in BMJ Open (Gethin et al., 2015). Evidence strength: preliminary — a single RCT with limited sample size.
Traditional use: Milk thistle has been used in European herbal medicine since antiquity, primarily for liver conditions, with its anti-inflammatory properties being a secondary application in skin and systemic disorders.
Scientific evidence: In a placebo-controlled study, a combination of milk thistle and methylsulfonylmethane (MSM) topically applied by forty-six persons for one month appeared to be effective for rosacea. Evidence strength: very preliminary — single small placebo-controlled study; no independent replication documented.
Sun exposure is one of the most commonly cited triggers for flushing and worsening of rosacea symptoms; exacerbations from UV radiation are thought to be the result of three processes: vitamin D inducing keratinocyte cathelicidin overexpression, which then initiates a pro-inflammatory cascade; UVB light increasing skin vasculature proliferation via FGF2 and VEGF2; and excess UV radiation increasing reactive oxygen species, further propagating the KLK5-cathelicidin inflammatory cascade.
Triggering factors including heat and stress are considered to be related to the initiation or aggravation of rosacea. Psychosocial factors, such as stress and social anxiety, may trigger and cause further deterioration of rosacea, resulting in higher incidences of depression and anxiety.
Triggers include hot temperatures, sun exposure, spicy foods, alcohol consumption, exercise, and feelings of anger or embarrassment; hot temperatures act directly to trigger vasodilatation.
Overall, dietary strategies that avoid common triggers such as alcohol, spicy foods, and histamine-rich products, while emphasizing nutrient-dense options like zinc, omega-3 fatty acids, and fiber, may aid in symptom management. High-fiber diets may support gut microbiota diversity and have anti-inflammatory effects, including on the skin; prebiotics, probiotics, and specific supplements may help shift the gut microbiome toward a profile that supports skin health, potentially improving rosacea symptoms; however, the available evidence is not definitive, and more rigorous studies are needed.
Rosacea is characterized by facial flushing, erythema, chronic inflammation, edema, and fibrosis; several trigger factors can worsen the disease or cause recurring episodes of inflammation. It is important to emphasize that triggers that affect one patient may not affect another; this is why there is a need for a personalized approach once patients have established what their particular dietary triggers are.
Vitamins and minerals hold potential in managing rosacea symptoms, offering a safe and cost-effective alternative or adjunctive treatment option; currently, there are no established recommendations regarding their supplementation for rosacea. Dysbiosis, small intestinal bacterial overgrowth, Helicobacter pylori infection, and innate immune system dysregulation mutually contribute to the pathophysiology of rosacea, but more extensive future research is needed to better clarify their precise mechanisms of action.
Allantoin is identified in peer-reviewed dermatology literature as one of the most effective OTC ingredients for rosacea redness reduction, often combined with bisabolol. A 2025 RCT (PMID 40177799, n=82) evaluated topical heparin sodium allantoin gel with quercetin in papulopustular rosacea, showing improvements in erythema scores and skin barrier function over 12 weeks.
A 2008 clinical study found that a cream containing 0.5% aloe vera extract was more effective than placebo in reducing rosacea-related redness and inflammation. Karger's 2026 rosacea plant extract narrative review classifies Aloe vera as having clinical evidence in related dermatological conditions. Dermatologists recommend it as a calming moisturizer ingredient for rosacea skin.
Asiaticoside, the principal triterpene glycoside of Centella asiatica, was evaluated in a vehicle-controlled half-side RCT (n=27) at 0.1%: significant reduction in inflammatory skin changes was observed. Centella asiatica (its source) is classified in Karger's 2026 rosacea review as having clinical evidence in rosacea-related conditions. It strengthens capillary walls and inhibits NF-κB.
FDA-approved at 15% prescription strength for inflammatory rosacea papules and pustules. Multiple clinical studies and a review of 20 trials confirm it reduces redness, bumps, and skin clarity better than vehicle. Works by directly inhibiting kallikrein-5 and cathelicidin (LL-37) inflammatory pathways central to rosacea pathogenesis.
Bisabolol, a chamomile-derived sesquiterpene alcohol, is identified in peer-reviewed dermatology literature as one of the most effective OTC ingredients for rosacea redness reduction. It inhibits COX and LOX inflammatory enzymes and stabilizes mast cells. Frequently included in rosacea skincare formulations and listed in rosacea product databases.
Butcher's Broom (Ruscus aculeatus) is classified in Karger's 2026 peer-reviewed rosacea plant extract narrative review as a botanical with clinical evidence in rosacea-related dermatological conditions. Its steroidal saponins (ruscogenins) reduce capillary permeability and venous tone, addressing vascular components central to rosacea.
Centella asiatica (gotu kola) contains pentacyclic triterpenoids (asiaticoside, madecassoside) with anti-inflammatory and vascular-strengthening effects. Karger's 2026 rosacea plant extract review classifies it as having clinical evidence in rosacea-related conditions. It appears in an RCT polyherbal formula that reduced facial redness by 40% in rosacea patients.
Centella triterpenes (asiaticoside, madecassoside, asiatic acid, madecassic acid) are the primary bioactives of Centella asiatica, classified in Karger's 2026 rosacea review as having clinical evidence in rosacea-related conditions. They inhibit NF-κB, reduce inflammatory cytokines, and strengthen vascular connective tissue relevant to rosacea erythema and telangiectasia.
Rosacea is characterized by impaired skin barrier function with reduced ceramide levels in affected facial skin, contributing to symptoms such as stinging, burning, and erythema. A dermatologist panel consensus review and an evidence-based clinical algorithm both identify ceramide-containing moisturizers as beneficial adjuncts for rosacea management, recommended before, during, and after prescription therapy. The evidence base is primarily expert consensus and observational, with limited RCT data specifically isolating ceramide's contribution.
Chamomile (Matricaria recutita) contains bisabolol, chamazulene, and apigenin, which inhibit COX and LOX pathways. Clinical studies show anti-inflammatory effects comparable to hydrocortisone 0.25% for eczematous skin symptoms shared with rosacea. Karger's 2026 rosacea review classifies chamomile as having preclinical and clinical data (golden chamomile) or clinical data in related conditions (German chamomile).
A PMC-indexed cell biology study demonstrated that Coptis chinensis extract directly inhibited kallikrein 5 (KLK5) and cathelicidin activation in human keratinocytes—key drivers of rosacea pathophysiology—and inhibited LL-37-induced endothelial proliferation associated with erythematous rosacea.
Curcumin, the primary polyphenol of turmeric, inhibits NF-κB, COX-2, and pro-inflammatory cytokines (IL-1β, IL-6, TNF-α) implicated in rosacea. Reviewed in J Drugs Dermatol 2018 (PMID 29879248) as a biologically-based rosacea therapy. Active compound in the polyherbal RCT that reduced rosacea facial redness by 40%.
DHA is an omega-3 fatty acid reviewed alongside EPA in the Archives of Dermatological Research 2024 systematic analysis (PMC11065919) of rosacea vitamins and nutrients. Combined EPA+DHA significantly improved ocular rosacea (xerophthalmia) in a clinical study (64% of patients). DHA reduces systemic inflammation via D-series resolvins and supports meibomian gland lipid quality.
EGCG, the primary bioactive catechin of green tea, has been shown to reduce papulopustular rosacea lesion count. Topical green tea polyphenols (predominately EGCG) produced ~25% reduction in rosacea symptoms (PMID 23346663). Reviewed as an evidence-based complementary rosacea therapy in J Drugs Dermatol 2018.
EPA is an omega-3 fatty acid reviewed in the Archives of Dermatological Research 2024 systematic analysis (PMC11065919) of vitamins and nutrients in rosacea. Combined EPA+DHA supplementation significantly improved xerophthalmia in 64–65% of ocular rosacea patients. EPA reduces inflammatory cytokines and supports meibomian gland function critical for ocular rosacea.
Feverfew (Tanacetum parthenium) parthenolide-depleted (PD-Feverfew) topical extract showed 60% reduction in UV-induced IL-1α release in a preclinical model. It inhibits COX, LOX, and serotonin pathways relevant to rosacea inflammation and flushing. Reviewed as a biologically-based rosacea therapy in J Drugs Dermatol 2018 (PMID 29879248).
Glabridin, a principal isoflavane of licorice root, inhibits cyclooxygenase and NF-κB-driven inflammation and reduces skin redness. It is cited in peer-reviewed dermatology literature as a key licorice compound that calms skin and reduces rosacea-related redness, alongside glycyrrhizin. Present in clinically studied licorice-based rosacea formulations.
Gotu Kola (Centella asiatica) is classified in Karger's 2026 peer-reviewed rosacea narrative review as having clinical evidence in rosacea-related dermatological conditions. Its triterpenoids reduce inflammation and strengthen capillary walls. It was included in an RCT polyherbal formula that produced 40% reduction of facial redness in rosacea patients.
Topical green tea polyphenols showed a ~25% reduction in rosacea symptoms in a published clinical study (Skinmed 2012, PMID 23346663). A topical combination of green tea polyphenols, resveratrol, and caffeine improved facial redness in 16 rosacea patients over 6 weeks. Karger's 2026 rosacea plant extract review classifies green tea leaf as having clinical evidence in rosacea-related conditions.
Licochalcone A from licorice root significantly reduced facial erythema in an open-label study of 62 rosacea patients over 8 weeks. Combined with metronidazole, it was well-tolerated in 25 patients. Karger's 2026 rosacea review and a ResearchGate systematic review both identify licorice among botanicals with preclinical and clinical data in rosacea.
Silymarin from milk thistle (Silybum marianum) reduced facial redness in 29/32 rosacea participants in an open-label trial with twice-daily topical cream over 12 weeks. Combined with MSM in a double-blind RCT (n=46), it significantly improved redness, papules, itching, and hydration versus placebo (P<0.001). Karger's 2026 rosacea review lists milk thistle with both preclinical and clinical data.
In a double-blind, placebo-controlled RCT (Berardesca et al. 2008, PMID 18254805, n=46), topical MSM combined with silymarin significantly reduced rosacea erythema, papules, itching, and improved skin hydration (P<0.001). MSM provides bioavailable sulfur for collagen support and exerts anti-inflammatory and antioxidant effects.
Colloidal oatmeal (Avena sativa) is classified by Karger's 2026 peer-reviewed rosacea plant extract narrative review as a first-tier botanical with both preclinical and clinical data in rosacea. It improves skin barrier function through avenanthramide-mediated anti-inflammatory activity, beta-glucan barrier fortification, and saponin gentle cleansing.
Omega-3 fatty acids (EPA+DHA) significantly improved xerophthalmia (dry eye) in 64–65% of patients with ocular rosacea in a clinical study. A diet high in omega-3s reduced erythema and inflammation in rosacea-like murine models. Reviewed in Archives of Dermatological Research systematic analysis of vitamins and nutrients in rosacea (2024, PMC11065919).
Panthenol (provitamin B5) is specifically named by dermatologists in peer-reviewed rosacea literature (PMC10892689) as a recommended ingredient in calming moisturizers for rosacea-affected skin. It supports epidermal barrier repair, reduces TEWL, and attenuates inflammatory cytokine release in sensitized skin.
A 2025 PubMed-indexed RCT (PMID 40177799, n=82) evaluated topical compound heparin sodium allantoin gel containing quercetin (as the primary active from onion extract) in papulopustular rosacea, showing improvements in erythema scores and skin barrier function (TEWL, hydration) at 12 weeks. Quercetin also inhibits mast cell degranulation and NF-κB relevant to rosacea flushing.
A clinical study (Ferzli et al., J Drugs Dermatol 2013) combining topical resveratrol, green tea polyphenols, and caffeine found meaningful improvement in facial redness in 16 rosacea patients over 6 weeks. Resveratrol is reviewed as a biologically-based rosacea therapy in J Drugs Dermatol 2018 (PMID 29879248) alongside niacinamide, green tea, and zinc.
Silymarin (from milk thistle) is the active polyphenolic mixture in the pivotal rosacea RCT (Berardesca et al. 2008, n=46, PMID 18254805): topical silymarin plus MSM significantly improved rosacea redness, papules, itching, and hydration (P<0.001) versus placebo. Mechanistically it inhibits NF-κB and reactive oxygen species relevant to rosacea.
Tea tree oil (Melaleuca alternifolia) is particularly effective for rosacea with Demodex mite involvement. Reviewed in J Drugs Dermatol 2018 (PMID 29879248) as a biologically-based rosacea therapy. Its terpinen-4-ol exerts direct ovicidal and acaricidal effects on Demodex folliculorum, whose density correlates with rosacea severity (PubMed 28711190).
A 30-patient RCT using an Ayurvedic polyherbal oral formula containing turmeric (and licorice, gotu kola, and other herbs) produced a 40% reduction in facial redness in rosacea patients over 4 weeks versus placebo. Turmeric alone showed no significant effect, suggesting synergy. Reviewed in J Drugs Dermatol 2018 as a rosacea biologically-based therapy.
Topical niacinamide has been evaluated for rosacea in clinical studies, with evidence for anti-inflammatory activity and reduction of skin redness and blotchiness. A 2004 PubMed review confirmed demonstrable anti-inflammatory effects in rosacea. Multiple dermatology references including DermNet NZ and peer-reviewed reviews list rosacea as a studied indication for topical nicotinamide.
Topical niacinamide (vitamin B3) has demonstrated efficacy in rosacea in multiple clinical studies. In one study of 50 patients, twice-daily application reduced redness, dryness, and irritation within 4 weeks. Topical 1-methylnicotinamide 0.25% improved symptoms in 76.4% of rosacea patients in a published study.
Vitamin C (ascorbic acid) is reviewed as a biologically-based rosacea therapy in J Drugs Dermatol 2018 (PMID 29879248) and included in the Archives of Dermatological Research systematic review of vitamins and nutrients in rosacea (2024). It functions as an antioxidant and anti-inflammatory agent with collagen-stabilizing properties relevant to rosacea.
Vitamin D status is altered in rosacea patients, with deficiency linked to severity. Multiple studies examined vitamin D and cathelicidin in rosacea (Park et al. Ann Dermatol 2018; Ekiz et al. Cutan Ocul Toxicol 2014). The Archives of Dermatological Research 2024 systematic review assessed vitamin D in rosacea, though outcomes varied across studies.
Yarrow (Achillea millefolium) is classified in Karger's 2026 rosacea plant extract review as having clinical evidence in rosacea-related dermatological conditions. Its polysaccharide fraction (Am-25-d) reduces nuclear NF-κB concentration—a key early-stage rosacea inflammatory driver—in preclinical models. It contains anti-inflammatory flavonoids, phenols, and terpenoids.
A double-blind, placebo-controlled trial (Sharquie et al., Int J Dermatol 2006) showed oral zinc sulfate significantly improved rosacea severity scores after 3 months. Topical 5% zinc sulfate reduced acne rosacea severity with 40% moderate and 60% good responses. Zinc exerts anti-inflammatory and antimicrobial effects relevant to Demodex-associated rosacea.
Rosacea is a traditional Moroccan indication for topical argan oil. Anti-inflammatory, barrier-supportive, and antioxidant properties are mechanistically relevant to rosacea's pathophysiology. No human clinical trials in rosacea patients exist.
Boswellia (Indian frankincense) is cited in rosacea naturopathic literature as a potent anti-inflammatory for skin inflammation, with boswellic acids specifically inhibiting 5-lipoxygenase (leukotriene B4 synthesis). Used traditionally in Ayurvedic medicine for inflammatory skin conditions. Clinical evidence specific to rosacea is lacking; primary support is traditional use and mechanistic rationale.
The 2021 laboratory study of calendula's anti-inflammatory action explicitly identifies rosacea as a condition where iNOS-mediated inflammation makes calendula applicable. Its soothing, anti-inflammatory properties are used in cosmetic formulations for sensitive and rosacea-prone skin. Clinical trial evidence is absent.
H. italicum EO is traditionally used in aromatherapy for rosacea, broken capillaries, and facial redness, attributed to its anti-inflammatory, 'anticoagulant', and vascular-toning properties. No clinical trials specifically on rosacea patients exist; evidence is based on traditional practice and general anti-inflammatory mechanisms.
Sophora root (Ku Shen) is cited in TCM references for rosacea due to damp heat, with rutin's capillary-stabilizing properties mechanistically relevant to this condition. Vascular fragility and inflammation reduction by rutin may alleviate rosacea symptoms. Evidence remains traditional and mechanistic rather than from clinical trials.
Go back